109456 ⎘
Coculture with; Conditioned medium produced by blood or immune system cells Monocytes, macrophages
SYSTEMS AND METHODS FOR CELL CULTURING
#2MESENCHYMAL LINEAGE PRECURSOR OR STEM CELLS WITH ENHANCED IMMUNOSUPPRESSION
#3SYSTEMS AND METHODS FOR CELL CULTURING
#4IN VITRO CONSTRUCT USEFUL FOR DRUG TOXICITY SCREENING
#5CELL SYSTEM AND APPLICATION THEREOF, AND METHOD FOR ACTIVATING BROAD-SPECTRUM CANCER CELL-SPECIFIC T CELL
#6MACROPHAGE-DERIVED ENGINEERED VESICLES FOR TARGETED DELIVERY AND TREATMENT
#7SYSTEMS AND METHODS FOR CELL CULTURING
#8SPECIFIC T CELL FOR PREVENTING OR TREATING CANCER, AND PREPARATION METHOD THEREOF
#9XENO-FREE GENERATION OF TISSUE-SPECIFIC PROGENITOR CELLS
#10METHOD OF CANCER TREATMENT
#11Compositions And Methods For Making And Using Atherosclerotic Nanomatrix Vascular Sheets
#12METHOD FOR CULTURING NATURAL KILLER CELL, USING TRANSFORMED T CELL
#13QUALITY CONTROL METHODS FOR AUTOMATED CELL PROCESSING
#14SYSTEMS AND METHODS FOR CELL CULTURING
#15METHODS FOR EXPANDING T CELLS FOR THE TREATMENT OF CANCER AND RELATED MALIGNANCIES
#16SYSTEMS AND METHODS FOR CELL CULTURING
#17SYSTEMS AND METHODS FOR CELL CULTURING
#18NK CELLS EXHIBITING AN ADAPTIVE PHENOTYPE AND METHODS FOR PREPARING AND FOR USING
#19MODIFIED TUMOR INFILTRATING LYMPHOCYTE AND USE THEREOF
#20ORGANOID AND TUMOR-INFILTRATING LYMPHOCYTE CO-CULTURE FOR OPTIMIZATION OF PATIENT-SPECIFIC IMMUNOTHERAPY RESPONSE
#21PERSON-TAILORED T CELL COMPOSITION TARGETING MERKEL CELL CARCINOMA
#22NON-ALCOHOLIC FATTY LIVER ARTIFICIAL TISSUE MODEL
#23TUMOR PROXIMAL CELL COLLECTION
#24METHOD FOR ACTIVATING T CELLS FOR CANCER TREATMENT
#25NON-ALCOHOLIC FATTY LIVER ARTIFICIAL TISSUE MODEL
#26METHOD FOR THE PRODUCTION OF THYMOCYTE SUPERNATANT
#27DEVICE AND METHOD FOR OBTAINING IMMUNO-STIMULATORY ANTIGEN-PRESENTING CELLS
#28IN VITRO LIVER DISEASE MODEL USING TRIPLE CO-CULTURE AND PREPARATION METHOD THEREOF
#29IN VITRO MODEL OF LIVER STEATOHEPATITIS
#30PHARMACEUTICAL COMPOSITION AND METHOD FOR INDUCING AN IMMUNE RESPONSE
#31Immunotherapy against neuronal and brain tumors
#32SIRPa Deficient Macrophages for Treating Cancer
#33MACROPHAGE-DERIVED ENGINEERED VESICLES FOR TARGETED DELIVERY AND TREATMENT
#34SYSTEMS AND METHODS FOR CELL CULTURING
#35GENERATION OF MATURE KUPFFER CELLS
#36Systems and methods for cell culturing
#37INTERLEUKIN-27 PRODUCING B-CELLS AND USES THEREOF
#38THE PROCESS FOR MANUFACTURING OF ANTIGEN-SPECIFIC T LYMPHOCYTES
#39Systems and methods for cell culturing
#40METHODS FOR EXPANDING T CELLS FOR THE TREATMENT OF CANCER AND RELATED MALIGNANCIES
#41Systems and methods for cell culturing
#42COMPOSITION FOR TISSUE REGENERATION, METHOD OF PRODUCTION AND USES THEREOF
#43METHOD FOR CULTURING ALLOGENEIC IMMUNE CELL, IMMUNE CELL CULTURE OBTAINED THEREBY, AND IMMUNE CELL THERAPEUTIC AGENT COMPRISING SAME
#44Xeno-free generation of tissue-specific progenitor cells
#45MICROGLIA-SUFFICIENT BRAIN ORGANOIDS
#46RAPID AND EFFICIENT METHOD FOR EXPANDING HUMAN MESENCHYMAL STEM CELLS IN VITRO AND APPLICATION THEREOF
#47METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING INFLAMMATORY DISEASES
#48METHODS OF IDENTIFYING IMMUNOMODULATORY GENES
#49NK cells exhibiting an adaptive phenotype and methods for preparing and for using
#50Clinical Gene Signature-Based Human Cell Culture Model and Uses Thereof
#51Isolation of Mesenchymal Stromal Cells
#52Generating HPV antigen-specific cells from a naive T cell population
#53PRODUCTION OF A BIOENGINEERED LUNG
#54Generating HPV antigen-specific cells from a naive T cell population
#55Quality control methods for automated cell processing
#56Supernatant from a coculture of macrophages and irradiated leukocytes, for controlling tumour progression or restoring anti-tumor immunity
#57Systems and methods for cell culturing
#58Systems and methods for cell culturing
#59SYSTEMS AND METHODS FOR CELL CULTURING
#60Systems and methods for cell culturing
#61Systems and methods for cell culturing
#62Systems and methods for cell culturing
#63SINGLE B-CELL CULTIVATION METHOD
#64Culture vessel for three-dimensional cell cultivation and three-dimensional cell co-cultivation method using same
#65Method for activating T cells for cancer treatment
#66Immunotherapy against neuronal and brain tumors
#67MESENCHYMAL LINEAGE PRECURSOR OR STEM CELLS WITH ENHANCED IMMUNOSUPPRESSION
#68Methods for obtaining regulatory t cells and uses thereof
#69Method for activating T cells for cancer treatment
#70TREATMENT OF LIVER FAILURE WITH ACTIVATED T REGULATORY CELLS
#71Method for the production of thymocyte supernatant
#72Indole regulation of antigen presenting cells
#73Use of engineered liver tissue constructs for modeling liver disorders
#74Method for culturing natural killer cell, using transformed T cell
#75Three-dimensional in vitro lung model, process for preparing said model, and its use for determining and /or predicting the sensitizing effects of inhalable products
#76Immunotherapy against neuronal and brain tumors
#77Co-culture system and method for in vitro assessment of reverse cholesterol transport
#78Hydrogel encapsulated cells and anti-inflammatory drugs
#79Generation of cancer stem cells and use thereof
#80Method for obtaining microglia from pluripotent stem cells
#81TRANSFECTION OF DENDRITIC CELLS AND METHODS THEREFOR
#82Immunotherapy against neuronal and brain tumors
#83METHODS AND COMPOSITIONS FOR EXPANDING LONG-TERM HEMATOPOIETIC STEM CELL POPULATIONS
#84Cell derived extracellular vesicles for the treatment of diseases
#85Generating HPV antigen-specific cells from a naive T cell population
#86SINGLE B-CELL CULTIVATION METHOD
#87Xeno-free generation of tissue-specific progenitor cells
#88NK cells exhibiting an adaptive phenotype and methods for preparing and for using
#89Three-dimensional co-culture method for adipocytes and macrophages
#90DEVICE AND METHOD FOR OBTAINING IMMUNO-STIMULATORY ANTIGEN-PRESENTING CELLS
#91Methods for obtaining regulatory T cells and uses thereof
#92KAI1 PROTEIN CONTROLLING CELL CYCLE OF HEMATOPOIETIC STEM CELL, AND USE THEREOF
#93Clinical gene signature-based human cell culture model and uses thereof
#94Hydrogel encapsulated cells and anti-inflammatory drugs
#95In vitro propagation of
#96Methods and means of generating IL-17 associated antitumor effector cells by inhibition of NR2F6 inhibition
#97CD11 B[low] MACROPHAGES AND CONDITIONED MEDIA THEREOF FOR TREATING CANCER AND/OR FIBROSIS
#98POLYVALENT ANTI-TUMOR FIBROBLAST VACCINE
#99SYSTEMS AND METHODS FOR STUDYING INFLAMMATION-DRUG INTERACTIONS
#100Xeno-free generation of tissue-specific progenitor cells
#101Methods and compositions for expanding long-term hematopoietic stem cell populations
#102Tumor Targeted Sickle Erythroid Precursors, Progenitors and Hematopoietic Stem Cells, Induced Pluripotent Stem Cells, Microparticles and Liposomes for Treatment of Cancer
#103Immunogenic epitopes for immunotherapy
#104CD11 B[low] macrophages and conditioned media thereof for treating cancer and/or fibrosis
#105OSTEOGENIC DIFFERENTIATION OF MESENCHYMAL STEM CELLS
#106Artificial immune system: methods of use
#107Immunogenic epitopes for immunotherapy
#108Method for inducing human blood-born hematospheres through aggregate culture and expanding blood adult stem cells and progenitor cells, and stem cell prepared by the same
#109Reducer of immunosuppression by tumor cell and antitumor agent using the same
#110Hydrogel encapsulated cells and anti-inflammatory drugs
#111Xeno-free generation of tissue-specific progenitor cells
#112Artificial immune system: methods for making and use
#113Immunogenic epitopes for immunotherapy
#114REDUCER OF IMMUNOSUPPRESSION BY TUMOR CELL AND ANTITUMOR AGENT USING THE SAME
#115Immunogenic epitope for immunotherapy
#116Immunotherapeutic peptides against neuronal and brain tumors and related methods and compositions
#117Novel methods, compositions and devices for inducing neovascularization
#118Artificial immune system: methods for making and use